Cisapride in the treatment of visual hallucinations caused by vision loss: the Charles Bonnet syndrome
- PMID: 10438699
- DOI: 10.1097/00019442-199908000-00012
Cisapride in the treatment of visual hallucinations caused by vision loss: the Charles Bonnet syndrome
Abstract
The authors describe the use of cisapride (Propulsid), a potent 5-HT(3) antagonist, in the treatment of visual hallucinations in two patients with vision loss (the Charles Bonnet syndrome).
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Other Literature Sources